Arbutus Biopharma Corp (ABUS)

Typically moves ±3.99% on earnings

EARNINGS ANALYTICS

event_upcoming Est. Next Earnings: 2026-11-10 ESTIMATED

Arbutus Biopharma Corp (ABUS) has a 49-report earnings history dating back to May 14, 2014. Its average absolute post-earnings move is ±3.99%, and 34.7% of those reactions were positive. Its largest post-earnings gain was +19.27% (Nov 02, 2017) and its largest decline was -13.74% (Mar 04, 2021). The next earnings report is predicted for 2026-11-10 (estimated).

Earnings reactions

How ABUS moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±3.99%

Positive %

34.7%

Negative %

65.3%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 12, 2026	☀ PRE	-1.5%	open_in_new
May 13, 2026	☀ PRE	-0.23%	open_in_new
Mar 23, 2026	☀ PRE	+4.25%	open_in_new
Nov 13, 2025	☀ PRE	-5.79%	open_in_new
Aug 06, 2025	☀ PRE	+1.76%	open_in_new
May 14, 2025	☀ PRE	-0.94%	open_in_new
Mar 27, 2025	☀ PRE	-2.39%	open_in_new
Nov 06, 2024	☀ PRE	-1.01%	open_in_new
Aug 01, 2024	☀ PRE	+1.06%	open_in_new
May 02, 2024	☀ PRE	-0.37%	open_in_new
Feb 29, 2024	☀ PRE	-2.78%	open_in_new
Nov 07, 2023	☀ PRE	-1.6%	open_in_new
Aug 03, 2023	☀ PRE	-0.96%	open_in_new
May 04, 2023	☀ PRE	+1.59%	open_in_new
Mar 02, 2023	☀ PRE	+0%	open_in_new
Nov 09, 2022	☀ PRE	-0.81%	open_in_new
Aug 04, 2022	☀ PRE	+3.25%	open_in_new
May 05, 2022	☀ PRE	+2.41%	open_in_new
Mar 03, 2022	☀ PRE	-4.53%	open_in_new
Nov 04, 2021	☀ PRE	+0.78%	open_in_new
Aug 05, 2021	☀ PRE	+10.14%	open_in_new
May 05, 2021	☀ PRE	-11.11%	open_in_new
Mar 04, 2021	☀ PRE	-13.74%	open_in_new
Nov 05, 2020	☀ PRE	-6.21%	open_in_new
Aug 07, 2020	☀ PRE	-13.04%	open_in_new
May 11, 2020	☀ PRE	+6.67%	open_in_new
Mar 05, 2020	☀ PRE	-0.99%	open_in_new
Nov 06, 2019	☀ PRE	-2.68%	open_in_new
Aug 05, 2019	☽ POST	+3.12%	open_in_new
May 06, 2019	☽ POST	-6.08%	open_in_new
Mar 07, 2019	☽ POST	-7.96%	open_in_new
Nov 07, 2018	☽ POST	+9.09%	open_in_new
Aug 03, 2018	☽ POST	-2.07%	open_in_new
May 03, 2018	☽ POST	+0.85%	open_in_new
Mar 14, 2018	☽ POST	-7.08%	open_in_new
Nov 02, 2017	☽ POST	+19.27%	open_in_new
Aug 03, 2017	☽ POST	+1.47%	open_in_new
May 04, 2017	☽ POST	-1.49%	open_in_new
Mar 21, 2017	☀ PRE	-4.48%	open_in_new
Nov 03, 2016	☽ POST	-3.28%	open_in_new
Aug 05, 2016	☽ POST	-1.99%	open_in_new
May 04, 2016	☽ POST	-2.8%	open_in_new
Mar 09, 2016	☀ PRE	-2.02%	open_in_new
Nov 05, 2015	☽ POST	+2.77%	open_in_new
Aug 05, 2015	☽ POST	-3.68%	open_in_new
May 06, 2015	☽ POST	-3.81%	open_in_new
Mar 12, 2015	☽ POST	-0.39%	open_in_new
Nov 06, 2014	☽ POST	+6.28%	open_in_new
May 14, 2014	☽ POST	-2.91%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±3.99%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 25 →

Funds holding

$275903188

Total value held

Buying

19 added · 6 reduced

Morgan Stanley

$84951868 -31.64%

Blackrock, Inc.

$66077140 +6.16%

State Street Corp

$37772059 +24.07%

Barclays Plc

$20197987 -2.51%

Goldman Sachs Group Inc

$16832650 +218.67%

SEC Filing Types

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
SCHEDULE 13G	20260904	open_in_new SEC.gov
SC TO-I	20260824	open_in_new SEC.gov
8-K	20260821	open_in_new SEC.gov
SC TO-C	20260821	open_in_new SEC.gov
10-Q	20260812	open_in_new SEC.gov
8-K	20260812	open_in_new SEC.gov
SCHEDULE 13G/A	20260812	open_in_new SEC.gov
8-K	20260716	open_in_new SEC.gov
4	20260610	open_in_new SEC.gov
4	20260610	open_in_new SEC.gov

Frequently asked about ABUS earnings

When does Arbutus Biopharma Corp report earnings next? expand_more

Arbutus Biopharma Corp (ABUS)'s next earnings date is estimated for 2026-11-10. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does ABUS stock move after earnings? expand_more

Over 49 reports, ABUS has moved an average of ±3.99% the session after earnings, closing higher 34.7% of the time.

What was ABUS's biggest post-earnings move? expand_more

ABUS's largest post-earnings gain on record was +19.27% on Nov 02, 2017, and its largest decline was -13.74% on Mar 04, 2021.

Where can I find Arbutus Biopharma Corp's SEC filings? expand_more

All of Arbutus Biopharma Corp's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.